Results 111 to 120 of about 2,075 (199)

Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin [PDF]

open access: yes, 2012
Human gene-2 (H2) relaxin is currently in Phase III clinical trials for the treatment of acute heart failure. It is a 53-amino acid insulin-like peptide comprising two chains and three disulfide bonds. It interacts with two of the relaxin family peptide (
Akhter Hossain   +48 more
core   +1 more source

Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis

open access: yesBritish Journal of Pharmacology, Volume 181, Issue 14, Page 2302-2318, July 2024.
Class A, rhodopsin‐like, G‐protein‐coupled receptors (GPCRs) are by far the largest class of GPCRs and are integral membrane proteins used by various cells to convert extracellular signals into intracellular responses. Initially, class A GPCRs were believed to function as monomers, but a growing body of evidence has emerged to suggest that these ...
Chrishan S. Samuel   +3 more
wiley   +1 more source

In vitro effects of relaxin on gene expression in porcine cumulus-oocyte complexes and developing embryos

open access: yesReproductive Biology and Endocrinology, 2011
Background Relaxin hormone peptide is found in porcine follicular and utero-tubal fluids, but its possible actions during early embryo development are still undetermined.
Willard Scott T   +3 more
doaj   +1 more source

Discovery of First-in-Class Small Molecule Agonists of the RXFP2 Receptor as Therapeutic Candidates for Osteoporosis [PDF]

open access: yes, 2022
Osteoporosis is a chronic bone disease characterized by decreased bone mass and increased risk of developing fractures, predominantly observed in the elderly.
Esteban Lopez, Maria
core   +1 more source

Targeting G protein‐coupled receptors for heart failure treatment

open access: yesBritish Journal of Pharmacology, Volume 181, Issue 14, Page 2270-2286, July 2024.
Heart failure remains a leading cause of morbidity and mortality worldwide. Current treatment for patients with heart failure include drugs targeting G protein‐coupled receptors such as β‐adrenoceptor antagonists (β‐blockers) and angiotensin II type 1 receptor antagonists (or angiotensin II receptor blockers).
Bui San Thai   +8 more
wiley   +1 more source

Genomic prediction of the polled and horned phenotypes in Merino sheep

open access: yesGenetics Selection Evolution, 2018
Background In horned sheep breeds, breeding for polledness has been of interest for decades. The objective of this study was to improve prediction of the horned and polled phenotypes using horn scores classified as polled, scurs, knobs or horns.
Naomi Duijvesteijn   +3 more
doaj   +1 more source

Ovarian Expression of Insulin-Like Peptide 3 (INSL3) and Its Receptor (RXFP2) During Development of Bovine Antral Follicles and Corpora Lutea and Measurement of Circulating INSL3 Levels During Synchronized Estrous Cycles [PDF]

open access: bronze, 2013
Leanne Satchell   +8 more
openalex   +1 more source

Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis

open access: yesiScience, 2019
Summary: The peptide hormone H2 relaxin has demonstrated promise as a therapeutic, but mimetic development has been hindered by the poorly understood relaxin receptor RXFP1 activation mechanism.
Bradley L. Hoare   +8 more
doaj   +1 more source

Whole-genome sequences of 89 Chinese sheep suggest role of RXFP2 in the development of unique horn phenotype as response to semi-feralization [PDF]

open access: gold, 2018
Zhangyuan Pan   +32 more
openalex   +1 more source

Home - About - Disclaimer - Privacy